Journal
SCIENTIFIC REPORTS
Volume 11, Issue 1, Pages -Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41598-021-85399-9
Keywords
-
Categories
Funding
- Fondazione Citta della Speranza ONLUS
- German Research Foundation [CRC1054]
- Care-for-Rare Foundation
- Leona M. and Harry B. Helmsley Charitable Trust
- NIH [RC2DK122532]
- Canada Research Chair (Tier 1) in Pediatric IBD
- CIHR Foundation Grant
- NIDDK NIH [RC2DK118640]
Ask authors/readers for more resources
Novel biallelic CARMIL2 variants were identified in three patients with pediatric-onset IBD and one with APS. None of the patients showed overt clinical signs of immunodeficiency before diagnosis. Reduced CARMIL2 expression was observed in bowel biopsies of IBD patients, and altered expression pattern of the missense variant was revealed in transfected cells.
CARMIL2 is required for CD28-mediated co-stimulation of NF-kappa B signaling in T cells and its deficiency has been associated with primary immunodeficiency and, recently, very early onset inflammatory bowel disease (IBD). Here we describe the identification of novel biallelic CARMIL2 variants in three patients presenting with pediatric-onset IBD and in one with autoimmune polyendocrine syndrome (APS). None manifested overt clinical signs of immunodeficiency before their diagnosis. The first patient presented with very early onset IBD. His brother was found homozygous for the same CARMIL2 null variant and diagnosed with APS. Two other IBD patients were found homozygous for a nonsense and a missense CARMIL2 variant, respectively, and they both experienced a complicated postoperative course marked by severe infections. Immunostaining of bowel biopsies showed reduced CARMIL2 expression in all the three patients with IBD. Western blot and immunofluorescence of transfected cells revealed an altered expression pattern of the missense variant. Our work expands the genotypic and phenotypic spectrum of CARMIL2 deficiency, which can present with either IBD or APS, aside from classic immunodeficiency manifestations. CARMIL2 should be included in the diagnostic work-up of patients with suspected monogenic IBD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available